Handelsbanken Fonder AB Acquires 200 Shares of Inspire Medical Systems, Inc. (NYSE:INSP)

Handelsbanken Fonder AB increased its stake in Inspire Medical Systems, Inc. (NYSE:INSP) by 3.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 5,700 shares of the company’s stock after purchasing an additional 200 shares during the quarter. Handelsbanken Fonder AB’s holdings in Inspire Medical Systems were worth $1,160,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of INSP. McGlone Suttner Wealth Management Inc. purchased a new position in shares of Inspire Medical Systems during the 4th quarter valued at $27,000. NBC Securities Inc. bought a new stake in Inspire Medical Systems during the third quarter valued at about $34,000. RiverPark Advisors LLC purchased a new position in shares of Inspire Medical Systems in the third quarter valued at about $44,000. Arcadia Investment Management Corp MI boosted its stake in shares of Inspire Medical Systems by 44.5% in the third quarter. Arcadia Investment Management Corp MI now owns 224 shares of the company’s stock worth $44,000 after acquiring an additional 69 shares during the period. Finally, Headinvest LLC purchased a new stake in shares of Inspire Medical Systems during the third quarter worth about $48,000. 94.91% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Royal Bank of Canada assumed coverage on Inspire Medical Systems in a report on Friday, April 19th. They issued an “outperform” rating and a $285.00 price target on the stock. Truist Financial reissued a “buy” rating and issued a $280.00 target price on shares of Inspire Medical Systems in a report on Wednesday, March 20th. Stifel Nicolaus restated a “hold” rating and set a $210.00 target price on shares of Inspire Medical Systems in a research report on Tuesday, January 2nd. Morgan Stanley assumed coverage on shares of Inspire Medical Systems in a report on Tuesday, March 19th. They issued an “overweight” rating and a $250.00 price target on the stock. Finally, Mizuho reiterated a “buy” rating and issued a $250.00 price target on shares of Inspire Medical Systems in a research note on Wednesday, March 27th. Four research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $272.20.

Inspire Medical Systems Trading Up 2.8 %

Shares of NYSE:INSP opened at $237.45 on Monday. The company has a market cap of $7.19 billion, a price-to-earnings ratio of -320.88 and a beta of 1.37. Inspire Medical Systems, Inc. has a 12 month low of $123.27 and a 12 month high of $330.00. The company has a 50-day moving average price of $207.54 and a 200 day moving average price of $185.97.

Inspire Medical Systems (NYSE:INSP) last posted its quarterly earnings data on Tuesday, February 6th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.53. The business had revenue of $192.51 million during the quarter, compared to analyst estimates of $186.75 million. Inspire Medical Systems had a negative return on equity of 3.93% and a negative net margin of 3.39%. The company’s revenue for the quarter was up 39.6% on a year-over-year basis. During the same period last year, the company earned $0.10 EPS. As a group, equities analysts forecast that Inspire Medical Systems, Inc. will post -0.35 EPS for the current year.

Insider Activity at Inspire Medical Systems

In other Inspire Medical Systems news, CEO Timothy P. Herbert sold 40,000 shares of Inspire Medical Systems stock in a transaction on Monday, April 1st. The shares were sold at an average price of $205.09, for a total transaction of $8,203,600.00. Following the completion of the transaction, the chief executive officer now directly owns 63,658 shares of the company’s stock, valued at $13,055,619.22. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, CFO Richard Buchholz sold 15,000 shares of the company’s stock in a transaction that occurred on Wednesday, April 17th. The stock was sold at an average price of $230.03, for a total transaction of $3,450,450.00. Following the transaction, the chief financial officer now owns 28,271 shares of the company’s stock, valued at $6,503,178.13. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Timothy P. Herbert sold 40,000 shares of the stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $205.09, for a total value of $8,203,600.00. Following the completion of the sale, the chief executive officer now owns 63,658 shares in the company, valued at $13,055,619.22. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 76,371 shares of company stock worth $15,664,278. Company insiders own 4.10% of the company’s stock.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.